Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (41-50 of 408) with videos related to

Pageof 41
Sort By:
Diabetes Care|June 12, 2016
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" HypothesisEle Ferrannini, Michael Mark, Eric Mayoux
European Heart Journal|March 27, 2003
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortalityAndrea Natali, Antonio L'Abbate, Ele Ferrannini
Metabolism: Clinical and Experimental|March 31, 2020
New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspectiveNiki Katsiki, Ele Ferrannini, Christos Mantzoros
Diabetes Care|December 8, 2016
Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122Ele Ferrannini, Michael Mark, Eric Mayoux
Diabetes Care|November 24, 2016
Response to Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114Ele Ferrannini, Michael Mark, Eric Mayoux
The Medical Clinics of North America|February 2, 2011
Pathophysiology of prediabetesEle Ferrannini, Amalia Gastaldelli, Patricia Iozzo
Diabetologia|March 4, 2014
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetesDavid Polidori, Andrea Mari, Ele Ferrannini
Hypertension (Dallas, Tex. : 1979)|September 4, 2003
Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertensionMichaela Kozàkovà, Ele Ferrannini, Carlo Palombo
Nature Medicine|January 7, 2006
Diabetes research investment in the European UnionPhilippe A Halban, Ele Ferrannini, Jørn Nerup
Diabetes Care|July 1, 2009
Redefining the diagnosis of diabetes using glycated hemoglobinVivian Fonseca, Silvio E Inzucchi, Ele Ferrannini
Pageof 41

Showing results (41-50 of 408) with videos related to

Sort By:
Pageof 41
Diabetes Care|June 12, 2016
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" HypothesisEle Ferrannini, Michael Mark, Eric Mayoux
European Heart Journal|March 27, 2003
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortalityAndrea Natali, Antonio L'Abbate, Ele Ferrannini
Metabolism: Clinical and Experimental|March 31, 2020
New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspectiveNiki Katsiki, Ele Ferrannini, Christos Mantzoros
Diabetes Care|December 8, 2016
Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122Ele Ferrannini, Michael Mark, Eric Mayoux
Diabetes Care|November 24, 2016
Response to Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114Ele Ferrannini, Michael Mark, Eric Mayoux
The Medical Clinics of North America|February 2, 2011
Pathophysiology of prediabetesEle Ferrannini, Amalia Gastaldelli, Patricia Iozzo
Diabetologia|March 4, 2014
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetesDavid Polidori, Andrea Mari, Ele Ferrannini
Hypertension (Dallas, Tex. : 1979)|September 4, 2003
Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertensionMichaela Kozàkovà, Ele Ferrannini, Carlo Palombo
Nature Medicine|January 7, 2006
Diabetes research investment in the European UnionPhilippe A Halban, Ele Ferrannini, Jørn Nerup
Diabetes Care|July 1, 2009
Redefining the diagnosis of diabetes using glycated hemoglobinVivian Fonseca, Silvio E Inzucchi, Ele Ferrannini
Pageof 41